|This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.|
A product of the National Association of Specialty Pharmacy's (NASP) Center for Specialty Pharmacy Education(CSPE). View more NASP/CSPE Activities
Rheumatoid Arthritis (RA) is an autoimmune disease that affects 1-2% of people worldwide. The diagnosis of RA increases with age and is more commonly seen in women. RA has been shown to decrease life expectancy and is a major factor leading to adult disability. This educational activity will review the pathophysiology, clinical presentation, and diagnosis of RA. The current ACR guidelines for treatment will be reviewed along with the current therapies. Methods used to measure and monitor the effectiveness of treatment, along with patient education, will also be discussed.
The target audience for this activity includes pharmacists. Upon completion of this activity, participants will be able to:
- Describe the clinical presentation of rheumatoid arthritis (RA) and the diagnostic criteria.
- Explain the 2015 American College of Rheumatology (ACR) recommendations for the treatment of RA.
- Summarize typical use, adverse effects, monitoring parameters and contraindication for non-biologic DMARDs, biologic DMARDs and small molecule therapies.
- Describe methods used to measure efficacy.
- Identify patient education considerations.
Kami Roake, PharmD
Gastroenterology & Rheumatology Pharmacist
University of Utah Hospitals & Clinics
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Kami Roake has no relevant commercial and/or financial relationships to disclose.
Release Date: June 1, 2020
Expiration Date: June 1, 2023
This CE activity is jointly provided by ProCE, Inc. and the National Association of Specialty Pharmacy (NASP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-219-H01-P has been assigned to this knowledge-based, home-study activity. This CE activity is approved for 1.5 contact hour (0.15 CEU) in states that recognize ACPE providers. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
No external support has been received for this activity.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.